Patents by Inventor Mary L. Owens

Mary L. Owens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8946274
    Abstract: Methods of improving skin quality are disclosed. Generally, the methods include topically administering an IRM compound to a treatment area of skin for a period of time and in an amount effective for improving the quality of the skin. Suitable IRM compound compounds include agonists of one or more TLRs.
    Type: Grant
    Filed: September 10, 2012
    Date of Patent: February 3, 2015
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Richard L. Miller, James H. Lee, Mary L. Owens
  • Patent number: 8835394
    Abstract: The present invention provides a method of treating basal cell carcinoma in a subject. Generally, the method includes administering to the subject an amount of IRM compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered.
    Type: Grant
    Filed: October 18, 2011
    Date of Patent: September 16, 2014
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Mary L. Owens, Terrance L. Fox, Angela M. Ginkel
  • Publication number: 20130149341
    Abstract: Methods of improving skin quality are disclosed. Generally, the methods include topically administering an IRM compound to a treatment area of skin for a period of time and in an amount effective for improving the quality of the skin. Suitable IRM compound compounds include agonists of one or more TLRs.
    Type: Application
    Filed: September 10, 2012
    Publication date: June 13, 2013
    Applicant: Medicis Pharmaceutical Corporation
    Inventors: Richard L. Miller, James H. Lee, Mary L. Owens
  • Patent number: 8426457
    Abstract: Methods of improving skin quality are disclosed. Generally, the methods include topically administering an IRM compound to a treatment area of skin for a period of time and in an amount effective for improving the quality of the skin. Suitable IRM compound compounds include agonists of one or more TLRs.
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: April 23, 2013
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Richard L. Miller, James H. Lee, Mary L. Owens
  • Publication number: 20120035205
    Abstract: The present invention provides a method of treating basal cell carcinoma in a subject. Generally, the method includes administering to the subject an amount of IRM compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered.
    Type: Application
    Filed: October 18, 2011
    Publication date: February 9, 2012
    Applicant: Graceway Pharmaceuticals. LLC
    Inventors: Mary L. Owens, Terrance L. Fox, Angela M. Ginkel
  • Publication number: 20110275662
    Abstract: Methods of improving skin quality are disclosed. Generally, the methods include topically administering an IRM compound to a treatment area of skin for a period of time and in an amount effective for improving the quality of the skin. Suitable IRM compound compounds include agonists of one or more TLRs.
    Type: Application
    Filed: July 14, 2011
    Publication date: November 10, 2011
    Inventors: Richard L. Miller, James H. Lee, Mary L. Owens
  • Publication number: 20100197722
    Abstract: The present invention provides a method of treating basal cell carcinoma in a subject. Generally, the method includes administering to the subject an amount of IRM compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered.
    Type: Application
    Filed: April 2, 2010
    Publication date: August 5, 2010
    Applicant: Graceway Pharmaceuticals, LLC
    Inventors: Mary L. Owens, Terrance L. Fox, Angela M. Ginkel
  • Patent number: 7696159
    Abstract: The present invention provides a method of treating basal cell carcinoma in a subject. Generally, the method includes administering to the subject an amount of IRM compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered.
    Type: Grant
    Filed: January 15, 2008
    Date of Patent: April 13, 2010
    Assignee: Graceway Pharmaceuticals, LLC
    Inventors: Mary L. Owens, Terrance L. Fox, Angela M. Ginkel
  • Publication number: 20090202443
    Abstract: Methods of improving skin quality are disclosed. Generally, the methods include topically administering an IRM compound to a treatment area of skin for a period of time and in an amount effective for improving the quality of the skin. Suitable IRM compound compounds include agonists of one or more TLRs.
    Type: Application
    Filed: April 17, 2009
    Publication date: August 13, 2009
    Inventors: Richard L. Miller, James H. Lee, Mary L. Owens
  • Publication number: 20040192585
    Abstract: The present invention provides a method of treating basal cell carcinoma in a subject. Generally, the method includes administering to the subject an amount of IRM compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered.
    Type: Application
    Filed: March 24, 2004
    Publication date: September 30, 2004
    Applicant: 3M Innovative Properties Company
    Inventors: Mary L. Owens, Terrance L. Fox, Angela M. Ginkel
  • Publication number: 20040180919
    Abstract: Methods of improving skin quality are disclosed. Generally, the methods include topically administering an IRM compound to a treatment area of skin for a period of time and in an amount effective for improving the quality of the skin. Suitable IRM compound compounds include agonists of one or more TLRs.
    Type: Application
    Filed: March 12, 2004
    Publication date: September 16, 2004
    Applicant: 3M Innovative Properties Company
    Inventors: Richard L. Miller, James H. Lee, Mary L. Owens